<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>05900741962474</udiDi>
    <basicUdiDi>B-05900741962474</basicUdiDi>
    <tradeName>Kropia Plus</tradeName>
    <deviceName></deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11380_PL</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:38:39.451Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741962412</udiDi>
    <basicUdiDi>B-05900741962412</basicUdiDi>
    <tradeName>Regenopia</tradeName>
    <deviceName>Regenopia</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11389_PL</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:38:35.675Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741962290</udiDi>
    <basicUdiDi>B-05900741962290</basicUdiDi>
    <tradeName>Eyeaze sodium hyaluronate 0,4% eye drops (Preservative free)</tradeName>
    <deviceName>ZUMA LONG RELIEF FREE,  LUBRICATING EYE DROPS 0,4, solution</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11397_EN</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:38:31.859Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741962283</udiDi>
    <basicUdiDi>B-05900741962283</basicUdiDi>
    <tradeName>Eyeaze sodium hyaluronate 0,2% eye drops (Preservative free)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11381_EN</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:38:09.130Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741962276</udiDi>
    <basicUdiDi>B-05900741962276</basicUdiDi>
    <tradeName>Eyeaze sodium hyaluronate 0,1% eye drops (Preservative free)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11392_EN</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:38:01.425Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741962269</udiDi>
    <basicUdiDi>B-05900741962269</basicUdiDi>
    <tradeName>KaliDrop Free</tradeName>
    <deviceName>KaliDrop Free</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11390_PL</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:37:57.645Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741962238</udiDi>
    <basicUdiDi>B-05900741962238</basicUdiDi>
    <tradeName>ZUMA świetlik PURE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11393_PL</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:37:53.834Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741962085</udiDi>
    <basicUdiDi>B-05900741962085</basicUdiDi>
    <tradeName>KOMPIN</tradeName>
    <deviceName>KOMPIN</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>12391_PL</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:37:19.559Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741962054</udiDi>
    <basicUdiDi>B-05900741962054</basicUdiDi>
    <tradeName>ZUMA n·oka + ulga dla oczu 0,1; NAWILŻAJĄCE KROPLE do oczu z hialuronianem sodu 0,1% oraz ekstraktem z ziela świetlika, roztwór</tradeName>
    <deviceName>ZUMA n·oka + ulga dla oczu 0,1; NAWILŻAJĄCE KROPLE do oczu z hialuronianem sodu 0,1% oraz ekstraktem z ziela świetlika, roztwór</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>12394_PL</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:37:11.446Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741962047</udiDi>
    <basicUdiDi>B-05900741962047</basicUdiDi>
    <tradeName>ZUMA n·oka ulga dla oczu 0,1; NAWILŻAJĄCE KROPLE do oczu z hialuronianem sodu 0,1%, roztwór</tradeName>
    <deviceName></deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>12392_PL</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:36:47.522Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741961224</udiDi>
    <basicUdiDi>B-05900741961224</basicUdiDi>
    <tradeName>ZUMA n·oka ulga dla oczu 0,4; NAWILŻAJĄCE KROPLE do oczu z hialuronianem sodu 0,4%, roztwór</tradeName>
    <deviceName>ZUMA n·oka ulga dla oczu 0,4; NAWILŻAJĄCE KROPLE do oczu z hialuronianem sodu 0,4%, roztwór</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>112396_PL</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:36:39.431Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900741961217</udiDi>
    <basicUdiDi>B-05900741961217</basicUdiDi>
    <tradeName>ZUMA n·oka ulga dla oczu 0,2; NAWILŻAJĄCE KROPLE do oczu z hialuronianem sodu 0,2%, roztwór</tradeName>
    <deviceName></deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>12395_PL</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-09-26T17:36:35.405Z</lastUpdated>
  </row>
  <row>
    <udiDi>05045099173360</udiDi>
    <basicUdiDi>B-05045099173360</basicUdiDi>
    <tradeName>Intensive Dry Eye Drops</tradeName>
    <deviceName>Intensive Dry Eye Drops</deviceName>
    <manufacturerName>SUPROBION Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000018264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11376_EN</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-09-25T19:28:55.537Z</lastUpdated>
  </row>
</eudamedExport>